An Overview of Central Nervous System Tumours
Abstract
Â
Doi: 10.28991/SciMedJ-2021-0304-8
Full Text: PDF
Keywords
References
Cojocaru, E., Mihăilă, D., Leon-Constantin, M. M., Cobzaru, R. G., Rîpă, C. V., Trandafirescu, M. F., & Trandafir, L. M. (2019). Update in pediatric primary brain tumors - from histology to genetically defined tumors. Romanian journal of morphology and embryology, 60(3):761—767. PMID: 31912084.
Reardon, D. A., Rich, J. N., Friedman, H. S., & Bigner, D. D. (2006). Recent advances in the treatment of malignant astrocytoma. Journal of Clinical Oncology, 24(8):1253–65. doi:10.1200/JCO.2005.04.5302.
Tohme, S., Simmons, R. L., & Tsung, A. (2017). Surgery for Cancer: A Trigger for Metastases. Cancer Research, 77(7):1548–1552. doi:10.1158/0008-5472.CAN-16-1536.
Gonzalez,J., & Gilbert, M. R. (2005). Treatment of astrocytomas. Current Opinion in Neurology,18(6):632–8. doi:10.1097/01.wco.0000191510.14627.d2.
Liu, R., Page M., Solheim K., Fox S., & Chang S. M. (2009). Quality of life in adults with brain tumors: Current knowledge and future directions. Neuro Oncology, 11(3):330–9. doi:10.1215/15228517-2008-093.
Kelly, P. (2010). Gliomas: Survival, origin and early detection. Surgical Neurology International, 1(1):96. doi:10.4103/2152-7806.74243.
Baskar,R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K. W. (2014). Biological response of cancer cells to radiation treatment. Frontiers in Molecular Biosciences, 1(24):1–9. doi:10.3389/fmolb.2014.00024.
Mohan, G., Hamna, A., Jijo, A. J., Devi, S., , Narayanasamy, A., & Vellingiri, B. (2019).. Recent advances in radiotherapy and its associated side effects in cancer—a review. The Journal of Basic and Applied Zoology, 80(1):1–10. doi:10.1186/s41936-019-0083-5.
Lauber, K., Ernst, A., Orth, M., Herrmann, M., & Belka, C. (2012). Dying cell clearance and its impact on the outcome of tumor radiotherapy. Frontiers in Oncology, 2(116):1–14. doi:10.3389/fonc.2012.00116.
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K. W. (2012). Cancer and radiation therapy: Current advances and future directions. International Journal of Medical Sciences, 9(3):193–9. doi:10.7150/ijms.3635.
Hoffman, C. (2007). Benefits of complementary therapies. Breast Cancer Research, 9(S2):1–3. doi:10.1186/bcr1807.
Bhowmik, A., Khan, R., Ghosh, M. K. (2015). Blood brain barrier: A challenge for effectual therapy of brain tumors. Biomedical Research International, 2015:1–20. doi:10.1155/2015/320941.
K. (2012). Chemotherapy and Dietary Phytochemical Agents. Chemotherapy Research and Practice, 2012:1–11. doi:10.1155/2012/282570.
Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., & Astsaturov, I. (2010). Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? Cancer Biology and Therapy, 10(9):839–53. doi:10.4161/cbt.10.9.13738.
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Advanced Pharmacuetical Bulletin. 7(3):339–48. doi:10.15171/apb.2017.041.
Housman, G., Byler, S., Heerboth, S., Lapinska, K., Longacre, M., Snyder, N., et al. (2014). Drug resistance in cancer: An overview. Cancers (Basel). 6(3):1769–92. doi:10.3390/cancers6031769.
Jäkel, S., & Dimou, L. (2017). Glial cells and their function in the adult brain: A journey through the history of their ablation. Frontiers in Cellular Neuroscience, 11(24), 1–17. doi:10.3389/fncel.2017.00024.
Nirzhor, S. S. R., Khan, R. I., Neelotpol, S. (2018) The biology of glial cells and their complex roles in Alzheimer’s disease: New opportunities in therapy. Biomolecules. 8(3):1–21. doi:10.3390/biom8030093.
Davis, M. E. (2016). Glioblastoma: Overview of disease and treatment. Clinical Journal of Oncology Nursing, 20(5), S2–S8. doi:10.1188/16.CJON.S1.2-8.
Zong, H., Parada, L. F., & Baker, S. J. (2015). Cell of origin for malignant gliomas and its implication in therapeutic development. Cold Spring Harbor Perspectives in Biology, 7(5), 1–13. doi:10.1101/cshperspect.a020610.
Wesseling, P., & Capper, D. (2018) WHO 2016 Classification of gliomas. Neuropathology and Applied Neurobiology,44(2):139–50. doi: 10.1111/nan.12432.
Rahmani, R., Tomlinson, S. B., Santangelo, G., Warren, K. T., Schmidt, T., Walter, K. A., & Vates, G. E. (2019). Risk factors associated with early adverse outcomes following craniotomy for malignant glioma in older adults. Journal of Geriatric Oncology, 11(4), 694–700. doi:10.1016/j.jgo.2019.10.019.
Walker, C., Baborie, A., Crooks, D., Wilkins, S., & Jenkinson, M. D. (2011). Biology, genetics and imaging of glial cell tumours. British Journal of Radiology, 84(2), S90–S106. doi:10.1259/bjr/2343.
Thurtle, D. R., Greenberg, D. C., Lee, L. S., Huang, H. H., Pharoah, P. D., & Gnanapragasam, V. J. (2019). Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the predict prostate multivariable model. PLoS Medicine, 16(3), 1–19. doi:10.1371/journal.pmed.1002758.
Walker, D. G., & Kaye, A. H. (2001). Diagnosis and management of astrocytomas, oligodendrogliomas and mixed gliomas: A review. Australasian Radiology, 45, 472–482. doi:10.1093/med/9780198570677.003.0295.
Larjavaara, S., Mäntylä, R., Salminen, T., Haapasalo, H., Raitanen, J., Jääskeläinen, J., & Auvinen, A. (2007). Incidence of gliomas by anatomic location. Neuro-Oncology, 9(3), 319–325. doi:10.1215/15228517-2007-016.
Sidoryk-Wegrzynowicz, M., & Aschner, M. (2013) Role of astrocytes in manganese mediated neurotoxicity. BMC Pharmacology and Toxicology, 14(23):1–10. doi:10.1186/2050-6511-14-23.
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001). Glial cell influence on the human blood-brain barrier. Glia, 36(2), 145–155. doi:10.1002/glia.1104.
Bello, L., Duffau, H., & Soffietti, R. (2012). Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology, 14, 55–64. doi:10.1093/neuonc/nos199.
Cserni, G. (2002). Tumour histological grade may progress between primary and recurrent invasive mammary carcinoma. Journal of Clinical Pathology, 55(4), 293–297. doi:10.1136/jcp.55.4.293.
Park, J. H., Jung, N., Kang, S. J., Kim, H. S., Kim, E., Lee, H. J., Jung, H. R., Choe, M., & Shim, Y. J. (2019). Survival and Prognosis of Patients with Pilocytic Astrocytoma: A Single-Center Study. Brain Tumor Research and Treatment, 7(2), 92–97. doi:10.14791/btrt.2019.7.e36.
Khaldi, A., Griauzde, J., DiPatri, A., Prabhu, V. C. (2012). Pilocytic Astrocytoma : A Comprehensive Review. Contemporary Neurosurgery, 33(10):1–6. doi: 10.1097/01.CNE.0000406545.01381.fc.
Findik, S. (2017). Primary Pilocytic Astrocytoma with Malign Transformation. Journal of Neurology & Stroke, 6(6), 4–6. doi:10.15406/jnsk.2017.06.00222.
Collins, V. P., Jones, D. T. W., & Giannini, C. (2015). Pilocytic astrocytoma: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 775–788. doi:10.1007/s00401-015-1410-7.
Fernandez, C., Figarella-Branger, D., Girard, N., Bouvier-Labit, C., Gouvernet, J., Paredes, A. P., Lena, G., Sindou, M. P., Rilliet, B., De Tribolet, N., Tomita, T., & Rutka, J. T. (2003). Pilocytic astrocytomas in children: Prognostic factors - A retrospective study of 80 cases. Neurosurgery, 53(3), 544–555. doi:10.1227/01.NEU.0000079330.01541.6E.
Han, T. (2017). Subependymal giant cell astrocytoma. Chinese Journal of Contemporary Neurology and Neurosurgery, 17(4), 310. doi:10.3969/j.issn.1672-6731.2017.04.015.
Grajkowska, W., Kotulska, K., Jurkiewicz, E., Roszkowski, M., Daszkiewicz, P., Jóźwiak, S., & Matyja, E. (2011). Subependymal giant cell astrocytomas with atypical histological features mimicking malignant gliomas. Folia Neuropathologica, 49(1), 39–46. PMID: 21455842.
Mei, G. H., Liu, X. X., Zhou, P., & Shen, M. (2017). Clinical and imaging features of subependymal giant cell astrocytoma: Report of 20 cases. Chinese Neurosurgical Journal, 3(1), 1–7. doi:10.1186/s41016-017-0077-4.
Ahmed, N., Alam, S., Islam, K. M. T., Haque, M., & Ahsan, A. (2020). Subependymal giant cell astrocytoma associated with hyperproteinorrhachia , presented with vp shunt malfunction : a rare clinical entity. Journal of Neurology & Stroke, 10(3), 97–99. doi:10.15406/jnsk.2020.10.00418.
Nowaczewska, M., & Kaźmierczak, H. (2020). Cerebral blood flow in low intracranial pressure headaches—what is known? Brain Sciences, 10(2), 1–9. doi:10.3390/brainsci10010002.
Chan, M., & Amin-Hanjani, S. (2010). Cerebrospinal Fluid and its Abnormalities. Encyclopedia of Life Sciences, 1–9. doi:10.1002/9780470015902.a0002191.pub2.
Abid, M., Haroon, S., Memon, A. H., Ahmad, Z., Hasan, S. H. (2018). Pleomorphic xanthoastrocytoma: Clinicopathological spectrum of an intriguing neoplasm. Pakistan Journal of Medical Sciences. 34(2):277–81. doi:10.12669/pjms.342.14663.
Choudry, U. K., Khan, S. A., Qureshi, A., & Bari, E. (2016). Primary anaplastic pleomorphic xanthoastrocytoma in adults. Case report and review of literature. International Journal of Surgery Case Reports, 27, 183–188. doi:10.1016/j.ijscr.2016.08.022.
Watanabe, N., Ishikawa, E., Kohzuki, H., Sakamoto, N., Zaboronok, A., Matsuda, M., Shibuya, M., & Matsumura, A. (2020). Malignant transformation of pleomorphic xanthoastrocytoma and differential diagnosis: Case report. BMC Neurology, 20(1), 7–11. doi:10.1186/s12883-020-1601-2.
Shaikh, N., Brahmbhatt, N., Kruser, T. J., Kam, K. L., Appin, C. L., Wadhwani, N., Chandler, J., Kumthekar, P., & Lukas, R. V. (2019). Pleomorphic xanthoastrocytoma: a brief review. CNS Oncology, 8(3), CNS39. doi:10.2217/cns-2019-0009.
Cristiane M. Ida, Fausto J. Rodriguez, Peter C. Burger, Alissa A. Caron, S. M., Jenkins, Grant M. Spears, Dawn L. Aranguren, Daniel H. Lachance, and C., & Giannini. (2015). Pleomorphic Xanthoastrocytoma: Natural History and LongTerm Follow-Up. Brain Pathology, 25(5), 575–586. doi:10.1111/bpa.12217.Pleomorphic.
Zhang, S., & William, C. (2020). Educational Case: Histologic and Molecular Features of Diffuse Gliomas. Academic Pathology, 7, 1–12. doi:10.1177/2374289520914021.
Ryall, S., Tabori, U., & Hawkins, C. (2017). A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment. Brain Tumor Pathology, 34(2), 51–61. doi:10.1007/s10014-017-0282-z.
Ichimura, K., Narita, Y., & Hawkins, C. E. (2015). Diffusely infiltrating astrocytomas: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 789–808. doi:1007/s00401-015-1439-7.
Wesseling, P., Kros, J. M., & Jeuken, J. W. M. (2011). The pathological diagnosis of diffuse gliomas: Towards a smart synthesis of microscopic and molecular information in a multidisciplinary context. Diagnostic Histopathology, 17(11), 486–494. doi:10.1016/j.mpdhp.2011.08.005.
Kaminska, B., Czapski, B., Guzik, R., Król, S. K., & Gielniewski, B. (2019). Consequences of IDH1/2 mutations in gliomas and an assessment of inhibitors targeting mutated IDH proteins. Molecules, 24(5), 1–17. doi:10.3390/molecules24050968.
Liu, Y., Lang, F., Chou, F. J., Zaghloul, K. A., & Yang, C. (2020). Isocitrate dehydrogenase mutations in glioma: Genetics, biochemistry, and clinical indications. Biomedicines, 8(9), 1–19. doi:10.3390/BIOMEDICINES8090294.
Delgado-López, P. D., Corrales-GarcÃa, E. M., Martino, J., Lastra-Aras, E., & Dueñas-Polo, M. T. (2017). Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies. Clinical and Translational Oncology, 19(8), 931–944. doi:10.1007/s12094-017-1631-4.
Dotson, J., Nijim, A., Denning, K. L., Shweihat, Y., & Lebowicz, Y. (2018). A Rare Case of Metastases from a High-grade Astrocytoma to the Pleura, Bones, and Liver within Six Months of Diagnosis. Cureus, 10(8), 1–6. doi:10.7759/cureus.3234.
Dong, X., Noorbakhsh, A., Hirshman, B. R., Zhou, T., Tang, J. A., Chang, D. C., Carter, B. S., & Chen, C. C. (2014). Survival trends of grade I, II, and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010: A SEER-based analysis. Neuro-Oncology Practice, 3(1), 29–38. doi:10.1093/nop/npv016.
Grimm, S. A., & Chamberlain, M. C. (2016). Anaplastic astrocytoma. CNS Oncology, 5(3), 145–157. doi:10.2217/cns-2016-0002.
Collins, V. P. (2004). Brain tumours: Classification and genes. Neurology in Practice, 75(2), i2–i11. doi:10.1136/jnnp.2004.040337.
Haase, S., Nuñez, F. M., Gauss, J. C., Thompson, S., Brumley, E., Lowenstein, P., & Castro, M. G. (2020). Hemispherical pediatric high-grade glioma: Molecular basis and therapeutic opportunities. International Journal of Molecular Sciences, 21(24), 1–25. doi:10.3390/ijms21249654.
Dirven, L., Sizoo, E. M., & Taphoorn, M. J. B. (2015). Anaplastic gliomas: end-of-life care recommendations. CNS Oncology, 4(5), 357–365. doi:10.2217/cns.15.31.
Urbanska, K., Sokolowska, J., Szmidt, M., & Sysa, P. (2014). Glioblastoma multiforme - An overview. Wspolczesna Onkologia, 18(5), 307–312. doi:10.5114/wo.2014.40559.
Witoonpanich, P., Bamrungrak, K., Jinawath, A., Wongwaisayawan, S., Phudhichareonrat, S., & Witoonpanich, R. (2011). Glioblastoma multiforme at the corpus callosum with spinal leptomeningeal metastasis. Clinical Neurology and Neurosurgery, 113(5), 407–410. doi:10.1016/j.clineuro.2010.12.001.
Robert, M. C., & Wastie, M. E. (2008). Glioblastoma multiforme: A rare manifestation of extensive liver and bone metastases. Biomedical Imaging and Intervention Journal, 4(1), 2–5. doi:10.2349/biij.4.1.e3.
Hanif, F., Muzaffar, K., Perveen, K., Malhi, S. M., & Simjee, S. U. (2017). Glioblastoma multiforme: A review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pacific Journal of Cancer Prevention, 18(1), 3–9. doi:10.22034/APJCP.2017.18.1.3.
Minniti, G., Muni, R., Lanzetta, G., Marchetti, P., & Enrici, R. M. (2009). Chemotherapy for Glioblastoma: Current Treatment and Future Perspectives for Cytotoxic and Targeted Agents. Anticancer Research, 29, 5171–5184. PMID: 20044633.
Hadziahmetovic, M., Shirai, K., & Chakravarti, A. (2011). Recent advancements in multimodality treatment of gliomas. Future oncology (London, England), 7(10), 1169–1183. doi:10.2217/fon.11.102.
Wu, J., Armstrong, T. S., & Gilbert, M. R. (2016). Biology and management of ependymomas. Neuro-Oncology, 18(7), 902–913. doi:10.1093/neuonc/now016.
Brinker, T., Stopa, E., Morrison, J., & Klinge, P. (2014). A new look at cerebrospinal fluid circulation. Fluids and Barriers of the CNS, 11(1), 1–16. doi:10.1186/2045-8118-11-10.
Fame, R. M., Cortés-Campos, C., & Sive, H. L. (2020). Brain Ventricular System and Cerebrospinal Fluid Development and Function: Light at the End of the Tube: A Primer with Latest Insights. BioEssays, 42(3), 1–15. doi:10.1002/bies.201900186.
Stiller, C. A., Bayne, A. M., Chakrabarty, A., Kenny, T., & Chumas, P. (2019). Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: Population-based study. BMC Cancer, 19(1), 1–15. doi:10.1186/s12885-019-5344-7.
Purdy, E., Johnston, D. L., Bartels, U., Fryer, C., Carret, A. S., Crooks, B., Eisenstat, D. D., Lafay-Cousin, L., Larouche, V., Wilson, B., Zelcer, S., Silva, M., Bouffet, E., Keene, D., & Strother, D. R. (2014). Ependymoma in children under the age of 3 years: A report from the Canadian Pediatric Brain Tumour Consortium. Journal of Neuro-Oncology, 117(2), 359–364. doi:10.1007/s11060-014-1396-3.
American Brain Tumour Association. Ependymoma. Available online: https://www.abta.org/wp-content/uploads/2018/03/ ependymoma-brochure.pdf (accessed on March 2021).
Fernández, I. S., & Loddenkemper, T. (2017). Seizures caused by brain tumors in children. Seizure, 44, 98–107. doi:10.1016/j.seizure.2016.11.028.
Sasaki, A., Hirato, J., Hirose, T., Fukuoka, K., Kanemura, Y., Hashimoto, N., Kodama, Y., Ichimura, K., Sakamoto, H., & Nishikawa, R. (2019). Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome. Brain Tumor Pathology, 36(2), 92–101. doi:10.1007/s10014-019-00338-x.
Jain, A., Amin, A. G., Jain, P., Burger, P., Jallo, G. I., Lim, M., & Bettegowda, C. (2012). Subependymoma: Clinical features and surgical outcomes. Neurological Research, 34(7), 677–684. doi:10.1179/1743132812Y.0000000064.
Scheinker, I. M. (1944). Subependymoma: a newly recognized tumor of subependymal derivation. 1–9. doi:10.3171/jns.1945.2.3.0232.
Koutourousiou, M., Georgakoulias, N., Kontogeorgos, G., & Seretis, A. (2009). Subependymomas of the lateral ventricle: Tumor recurrence correlated with increased Ki-67 labeling index. Neurology India, 57(2), 191–193. doi:10.4103/0028-3886.51293.
Ragel, B. T., Osborn, A. G., Whang, K., Townsend, J. J., Jensen, R. L., & Couldwell, W. T. (2006). Subependymomas: An analysis of clinical and imaging features. Neurosurgery, 58(5), 881–889. doi:10.1227/01.NEU.0000209928.04532.09.
Smith, A. B., Smirniotopoulos, J. G., & Horkanyne-Szakaly, I. (2013). From the radiologic pathology archives: Intraventricular neoplasms: Radiologic-pathologic correlation. Radiographics, 33(1), 151–154. doi:10.1148/rg.331125192.
Kim, Y., Lee, S. Y., Yi, K. S., Cha, S. H., Gang, M. H., Cho, B. S., & Lee, Y. M. (2014). Infratentorial and intraparenchymal subependymoma in the cerebellum: Case Report. Korean Journal of Radiology, 15(1), 151–155. doi:10.3348/kjr.2014.15.1.151.
Iddrissu, M., Dakurah, T., & Wepeba, G. (2006). Anaplastic ependymoma of the fourth ventricle causing obstrictive hydrocephalus. Ghana Medical Journal, 39(1), 33–36. doi:10.4314/gmj.v39i1.35979.
Fonseca, L., Cicuendez, M., MartÃnez-Ricarte, F., MartÃnez-Saez, E., Cordero, E., & Bescos, A. (2019). A rare case of an intramedullary metastasis of a myxopapillary ependymoma. Surgical Neurology International, 10(83), 1–4. doi:10.25259/sni-96-2019.
Celano, E., Salehani, A., Malcolm, J. G., Reinertsen, E., Hadjipanayis, C. G., Sinai, M., Israel, B., & Ambulatory, P. (2016). Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neurooncol, 128(3), 377–386. doi:10.1007/s11060-016-2135-8.Spinal.
Koeller, K. K., Rosenblum, R. S., & Morrison, A. L. (2000). Neoplasms of the Spinal Cord and Filum Terminale: Radiologic-Pathologic Correlation. Radiographics, 20(6), 1721–1749. doi:10.1007/978-3-540-85019-9_15.
Bandopadhayay, P., Silvera, V. M., Ciarlini, P. D. S. C., Malkin, H., Bi, W. L., Bergthold, G., Faisal, A. M., Ullrich, N. J., Marcus, K., Scott, R. M., Beroukhim, R., Manley, P. E., Chi, S. N., Ligon, K. L., Goumnerova, L. C., & Kieran, M. W. (2016). Myxopapillary ependymomas in children: imaging, treatment and outcomes. Journal of Neuro-Oncology, 126(1), 165–174. doi:10.1007/s11060-015-1955-2.
Carter, M., Nicholson, J., Ross, F., Crolla, J., Allibone, R., Balaji, V., Perry, R., Walker, D., Gilbertson, R., & Ellison, D. (2002). Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. British Journal of Cancer, 86(6), 929–939. doi:10.1038/sj.bjc.6600180.
Shirasawa, H., Ishii, K., Iwanami, A., Mikami, S., Toyama, Y., Matsumoto, M., & Nakamura, M. (2014). Pediatric myxopapillary ependymoma treated with subtotal resection and radiation therapy: A case report and review of the literature. Spinal Cord, 52(SUPPL. 2), 18–20. doi:10.1038/sc.2014.95.
Samartzis, D., Gillis, C. C., Shih, P., Toole, J. E. O., & Fessler, R. G. (2015). Intramedullary Spinal Cord Tumors : Part I - Epidemiology, Pathophysiology, and Diagnosis. Global Spine Journal, 5(5), 425–435. doi:10.1055/s-0035-1549029.
Shinde, S. M., Kumbhar, U. R., Deshmukh, D. B., Gaikwad, D. D., & Grampurohit, N. D. (2013). A review: Ependymomas disease. International Journal of Pharmaceutical and Clinical Research, 5(2), 47–63. ISSN:0975 1556.
Dulai, M. S., Caccamo, D. V., Briley, A. L., Edwards, M. S. B., Fisher, P. G., & Lehman, N. L. (2010). Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain. Journal of Neurosurgery: Pediatrics, 5(5), 511–517. doi:10.3171/2009.12.PEDS09130.
Maity, P., Chaudhuri, Debashis, Chakrabarty, Shubhamitra, Chaudhuri, & Chatterjee, U. (2019). Papillary Ependymoma of the Spinal Cord: A Case Report with Summary of Prior Published Cases. Asian Journal of Neurosurgery, 14(1), 223–226. doi:10.4103/ajns.AJNS.
Sheen Kweh, B. T., Rosenfeld, J., Hunn, M., & Tee, J. W. (2021). The Effects of Surgery and Adjuvant Therapy on Survival Outcomes in Clear Cell Ependymomas: A Systematic Review and Meta-Analysis of Individual Patient Data. World Neurosurgery, 145, 229–240. doi:10.1016/j.wneu.2020.09.044.
Lee, B. H., Kwon, J. T., & Park, Y. S. (2011). Supratentorial clear cell ependymoma Mimicking oligodendroglioma: Case report and review of the literature. Journal of Korean Neurosurgical Society, 50(3), 240–243. doi:10.3340/jkns.2011.50.3.240.
Deb, P., Manu, V., Pradeep, H., & Bhatoe, H. (2011). Intraparenchymal clear cell ependymoma. Journal of Cytology, 28(2), 73–76. doi:10.4103/0970-9371.80747.
Krisht, K. M., & Schmidt, M. H. (2013). Tanycytic Ependymoma: A Challenging Histological Diagnosis. In Case Reports in Neurological Medicine (Vol. 2). doi:10.1155/2013/170791.
Lehman, N. L. (2008). Central nervous system tumors with ependymal features: A broadened spectrum of primarily ependymal differentiation? Journal of Neuropathology and Experimental Neurology, 67(3), 177–188. doi:10.1097/NEN.0b013e31816543a6.
Zhang, S., Wang, X., Zhang, Z., & Chen, Y. (2008). Tanycytic ependymoma arising from the right lateral ventricle: A case report and review of the literature. Neuropathology, 28(4), 427–432. doi:10.1111/j.1440-1789.2007.00857.x.
Lee, J., Chung, S. Y., Han, J. W., Kim, D. S., Kim, J., Moon, J. Y., Yoon, H. I., & Suh, C. O. (2020). Treatment outcome of anaplastic ependymoma under the age of 3 treated by intensity-modulated radiotherapy. Radiation Oncology Journal, 38(1), 26–34. doi:10.3857/roj.2020.00073.
Bansal, K., Kongkham, P., & Rutka, J. T. (2006). Treatment Modalities for Ependymomas in Children. Contemporary Neurosurgery, 28(4), 1–7. doi:10.1097/00029679-200602280-00001.
Wesseling, P., van den Bent, M., & Perry, A. (2015). Oligodendroglioma: pathology, molecular mechanisms and markers. Acta Neuropathologica, 129(6), 809–827. doi:10.1007/s00401-015-1424-1.
Smits, M. (2016). Imaging of oligodendroglioma. Br J Radiol, 89(20150857), 1–11. doi:10.1016/B978-0-12-813158-9.00012-8.
Torensma, R. (2018). The dilemma of cure and damage in oligodendroglioma: Ways to tip the balance away from the damage. Cancers, 10(431), 1–10. doi:10.3390/cancers10110431.
Ohgaki, H., & Kleihues, P. (2005). Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. Journal of Neuropathology and Experimental Neurology, 64(6), 479–489. doi:10.1093/jnen/64.6.479.
Blakeley, J., & Grossman , S. (2008). Anaplastic Oligodendroglioma. Curr Treat Options Neurol, 10(4), 295–307. doi:10.1007/s11940-008-0032-y.
Burgy, M., Chenard, M. P., Noël, G., Bourahla, K., & Schott, R. (2019). Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: A case report. Journal of Medical Case Reports, 13(1), 1–5. doi:10.1186/s13256-019-2061-4.
Louis, D. N., Holland, E. C., & Cairncross, J. G. (2001). Glioma classification: A molecular reappraisal. American Journal of Pathology, 159(3), 779–786. doi:10.1016/S0002-9440(10)61750-6.
Engelhard, H. H. (2002). Current diagnosis and treatment of oligodendroglioma. Journal of Neurosurgery, 12(2), 1–7. doi:10.3171/foc.2002.12.2.3.
Lee, C. H., Jung, K. W., Yoo, H., Park, S., & Lee, S. H. (2010). Epidemiology of primary brain and central nervous system tumors in Korea. Journal of Korean Neurosurgical Society, 48(2), 145–152. doi:10.3340/jkns.2010.48.2.145.
Yamashima, T. (2009). Human Meninges: Anatomy and Its Role in Meningioma Pathogenesis. Meningiomas, 15–24. doi:10.1007/978-1-84628-784-8_3.
Sun, T., Plutynski, A., Ward, S., & Rubin, J. B. (2015). An integrative view on sex differences in brain tumors. Cellular and Molecular Life Sciences, 72(17), 3323–3342. doi:10.1007/s00018-015-1930-2.
Buerki, R. A., Horbinski, C. M., Kruser, T., Horowitz, P. M., James, C. D., & Lukas, R. V. (2018). An overview of meningiomas. Future Oncology, 14(21), 2161–2177. doi:10.2217/fon-2018-0006.
Harter, P. N., Braun, Y., & Plate, K. H. (2017). Classification of meningiomas-advances and controversies. Chinese Clinical Oncology, 6(2), 1–8. doi:10.21037/cco.2017.05.02.
Simpson D. (1957). The recurrence of intracranial meningiomas after surgical treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 20(1), 22–39. doi:10.1136/jnnp.20.1.22.
Lee, J. H., Kim, O. L., Seo, Y. B., & Choi, J. H. (2017). Prognostic factors of atypical meningioma: Overall survival rate and progression free survival rate. Journal of Korean Neurosurgical Society, 60(6), 661–666. doi:10.3340/jkns.2017.0303.008.
Sharifi, G., Lotfinia, M., Omidbeigi, M., Asaadi, S., & Zerehpoosh, F. B. (2020). Meningothelial meningioma of the oculomotor nerve: A case report and review of the literature. Surgical Neurology International, 11(314), 1–4. doi:10.25259/SNI_312_2020.
Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006). Histological classification and molecular genetics of meningiomas. Lancet Neurology, 5(12), 1045–1054. doi:10.1016/S1474-4422(06)70625-1.
Samundeeswari, R. Kannan, P. (2019). A Retrospective Study of Histopathology and Clinical Correlation of Spinal Meningioma at Thoothukudi Medical. Medical and Dental Research, 5(5), 1–11. doi:10.21276/aimdr.2019.5.5.PT1.
Li, J., Fang, L., Killer, H. E., Flammer, J., Meyer, P., & Neutzner, A. (2013). Meningothelial cells as part of the central nervous system host defence. Biology of the Cell, 105(7), 304–315. doi:10.1111/boc.201300013.
Bhat, A. R., Wani, M. A., Kirmani, A. R., & Ramzan, A. U. (2014). Histological-subtypes and anatomical location correlated in meningeal brain tumors (meningiomas). Journal of Neurosciences in Rural Practice, 5(3), 244–249. doi:10.4103/0976-3147.133568.
Rushing, E. J., Bouffard, J. P., McCall, S., Olsen, C., Mena, H., Sandberg, G. D., & Thompson, L. D. R. (2009). Primary extracranial meningiomas: An analysis of 146 cases. Head and Neck Pathology, 3(2), 116–130. doi:10.1007/s12105-009-0118-1.
Jacobo, J. A., Mamani, R., Jimenez, S. M., Avendaño, J., & Nuñez, S. (2020). Microcystic meningioma associated with other meningioma subtypes: A diagnostic challenge, report of two cases. Interdisciplinary Neurosurgery: Advanced Techniques and Case Management, 19(100548), 1–5. doi:10.1016/j.inat.2019.100548.
Paik, S. S., Jang, S. J., Park, Y. W., Hong, E. K., Park, M. H., & Lee, J. D. (1996). Microcystic meningioma - A case report. In Journal of Korean Medical Science (Vol. 11, Issue 6, pp. 540–543). doi:10.3346/jkms.1996.11.6.540.
Kim, S. H., Kim, D. G., Kim, C. Y., Choe, G., Chang, K. H., & Jung, H. W. (2003). Microcystic Meningioma: The Characteristic Neuroradiologic Findings. Journal of Korean Neurosurgical Society, 34(5), 401-406.
Kim, J. H., Kim, Y. J., Kim, H., Nam, S. H., & Choi, Y. W. (2015). A rare case of transitional meningioma. Archives of Plastic Surgery, 42(3), 375–377. doi:10.5999/aps.2015.42.3.375.
Lee, W., Chang, K. H., Choe, G., Chi, J. G., Chung, C. K., Kim, I. H., Han, M. H., Park, S. W., Shin, S. J., & Koh, Y. H. (2000). MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. American Journal of Neuroradiology, 21(1), 130–132. PMID: 10669237.
Kunimatsu, A., Kunimatsu, N., Kamiya, K., Katsura, M., Mori, H., & Ohtomo, K. (2016). Variants of meningiomas: a review of imaging findings and clinical features. Japanese Journal of Radiology, 34(7), 459–469. doi:10.1007/s11604-016-0550-6.
Mishra, R. K., Vahikar, S. U., Singh, M., Lal, G. N., & Shrivastava, K. (2015). Angiomatous Meningioma Arising in Tonsil : A Rare Tumor at Rare Site. 3(7), 262–265. doi:10.17354/ijss/2015/491.
Liu, Z., Wang, C., Wang, H., Wang, Y., Li, J. Y., & Liu, Y. (2013). Clinical characteristics and treatment of angiomatous meningiomas: A report of 27 cases. International Journal of Clinical and Experimental Pathology, 6(4), 695–702. PMID: 23573316.
Regelsberger, J., Hagel, C., Emami, P., Ries, T., Heese, O., & Westphal, M. (2009). Secretory meningiomas: A benign subgroup causing life-threatening complications. Neuro-Oncology, 11(6), 819–824. doi:10.1215/15228517-2008-109.
Choi, Y.-H., Choi, C.-Y., Lee, C.-H., Koo, H.-W., & Chang, S.-H. (2018). Metaplastic Meningioma Overspreading the Cerebral Convexity. Brain Tumor Research and Treatment, 6(2), 97–100. doi:10.14791/btrt.2018.6.e17.
Tang, H., Sun, H., Chen, H., Gong, Y., Mao, Y., Xie, Q., Xie, L., Zheng, M., Wang, D., Zhu, H., Che, X., Zhong, P., Zheng, K., Li, S., Bao, W., Zhu, J., Wang, X., Feng, X., Chen, X., & Zhou, L. (2013). Clinicopathological analysis of metaplastic meningioma: Report of 15 cases in Huashan Hospital. Chinese Journal of Cancer Research, 25(1), 112–118. doi:10.3978/j.issn.1000-9604.2013.01.10.
Zhu, H. Da, Xie, Q., Gong, Y., Mao, Y., Zhong, P., Hang, F. P., Chen, H., Zheng, M. Z., Tang, H. L., Wang, D. J., Chen, X. C., & Zhou, L. F. (2013). Lymphoplasmacyte-rich meningioma: Our experience with 19 cases and a systematic literature review. International Journal of Clinical and Experimental Medicine, 6(7), 504–515. PMID: 23936588.
Ros-Sanjuan, A., Iglesias-Moroño, S., Carrasco-Brenes, A., Bautista-Ojeda, D., & Arraez-Sanchez, M. A. (2019). Atypical Meningiomas: Histologic and Clinical Factors Associated With Recurrence. World Neurosurgery, 125, e248–e256. doi:10.1016/j.wneu.2019.01.056.
Brokinkel, B., Hess, K., & Mawrin, C. (2017). Brain invasion in meningiomas-clinical considerations and impact of neuropathological evaluation: A systematic review. Neuro-Oncology, 19(10), 1298–1307. doi:10.1093/neuonc/nox071.
Backer-Grøndahl, T., Moen, B. H., & Torp, S. H. (2012). The histopathological spectrum of human meningiomas. International Journal of Clinical and Experimental Pathology, 5(3), 231–242. PMID: 22558478.
Zhang, H., Ma, L., Wang, Y. bo, Shu, C., Kuang, W., Huang, Y. an, Dong, L. qiang, & Cheng, G. ge. (2017). Intracranial Clear Cell Meningiomas: Study on Clinical Features and Predictors of Recurrence. World Neurosurgery, 97, 693-700.e11. doi:10.1016/j.wneu.2016.10.010.
Lee, W., Chang, K. H., Choe, G., Chi, J. G., Chung, C. K., Kim, I. H., Han, M. H., Park, S. W., Shin, S. J., & Koh, Y. H. (2000). MR imaging features of clear-cell meningioma with diffuse leptomeningeal seeding. American Journal of Neuroradiology, 21(1), 130–132. PMID: 10669237.
Prokopienko, M., Wierzba-Bobrowicz, T., Grajkowska, W., Stępień, T., & Sobstyl, M. (2020). Chordoid Meningioma: Case Report and Review of the Literature. Neurosurgery - Cases and Reviews, 3(2), 1–5. doi:10.23937/2643-4474/1710045.
Kepes, J. J., Chen, W. Y., Connors, M. H., & Vogel, F. S. (1988). “Chordoid†meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the castleman syndrome. A report of seven cases. Cancer, 62(2), 391–406. doi:10.1002/1097-0142(19880715)62:2<391::AID-CNCR2820620226>3.0.CO;2-7.
Hasegawa, S., Yoshioka, S., Urabe, S., & Kuratsu, J. I. (2006). Rapidly enlarging chordoid meningioma with abundant mucin production. Neuropathology, 26(5), 438–441. doi:10.1111/j.1440-1789.2006.00708.x.
Loewenstern, J., Shuman, W., Rutland, J. W., Kessler, R. A., Kohli, K. M., Umphlett, M., Pain, M., Bederson, J., Fowkes, M., & Shrivastava, R. K. (2019). Preoperative and Histological Predictors of Recurrence and Survival in Atypical Meningioma after Initial Gross Total Resection. World Neurosurgery, 128, e148–e156. doi:10.1016/j.wneu.2019.04.069.
Rogers, L., Barani, I., Chamberlain, M., Kaley, T. J., McDermott, M., Raizer, J., Schiff, D., Weber, D. C., Wen, P. Y., & Vogelbaum, M. A. (2015). Meningiomas: Knowledge base, treatment outcomes, and uncertainties. A RANO review. Journal of Neurosurgery, 122(1), 4–23. doi:10.3171/2014.7.JNS131644.
Millard, M. E., & De Braganca, K. C. (2016). Medulloblastoma. J Child Neurol, 31(12), 1341–1353. doi:10.1177/0883073815600866.Medulloblastoma.
Kijima, N., & Kanemura, Y. (2016). Molecular classification of medulloblastoma. Neurologia Medico-Chirurgica, 56(11), 687–697. doi:10.2176/nmc.ra.2016-0016.
Patay, Z., DeSain, L. A., Hwang, S. N., Coan, A., Li, Y., & Ellison, D. W. (2015). MR imaging characteristics of wingless-type-subgroup pediatric medulloblastoma. American Journal of Neuroradiology, 36(12), 2386–2393. doi:10.3174/ajnr.A4495.
Menyhárt, O., & Győrffy, B. (2019). Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas. Annals of Clinical and Translational Neurology, 6(5), 990–1005. doi:10.1002/acn3.762.
Ramaswamy, V., Nör, C., & Taylor, M. D. (2016). P53 and Meduloblastoma. Cold Spring Harbor Perspectives in Medicine, 6(2), 1–9. doi:10.1101/cshperspect.a026278.
Juraschka, K., & Taylor, M. D. (2019). Medulloblastoma in the age of molecular subgroups: A review: JNSPG 75th Anniversary invited review article. Journal of Neurosurgery: Pediatrics, 24(4), 353–363. doi:10.3171/2019.5.PEDS18381.
Zou, H., Poore, B., Broniscer, A., Pollack, I. F., & Hu, B. (2020). Molecular heterogeneity and cellular diversity: Implications for precision treatment in medulloblastoma. Cancers, 12(3). doi:10.3390/cancers1203064.
Vaidyanathan, G., Gururangan, S., Bigner, D., Zalutsky, M., Robert, P., & Brain, T. (2014). Medulloblastoma. Neuro-Oncology, 16(1), 71–96. doi:10.1093/neuonc/nou074.
Thomas, A., & Noël, G. (2019). Medulloblastoma: Optimizing care with a multidisciplinary approach. Journal of Multidisciplinary Healthcare, 12, 335–347. doi:10.2147/JMDH.S167808.
De Braganca, K. C., & Packer, R. J. (2016). Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET). Curr Treat Options Neurol, 15(5), 593–606. doi:10.1007/s11940-013-0255-4.Treatment.
Ortega-Merchan, M. P., Reyes, F., MejÃa, J. A., Rivera, D. M., Galvis, J. C., & Marquez, J. C. (2019). Cystic trigeminal schwannomas. Radiology case reports, 14(12), 1513–1517. doi:10.1016/j.radcr.2019.09.031.
Swami, P., Raval, R., Kumawat, V., & Nyklesh, V. (2019). Maxillary schwannoma - A case report of a rare tumor. National Journal of Maxillofacial Surgery, 10(2), 245–248. doi:10.4103/njms.NJMS_1_16.
Zheng, X., Guo, K., Wang, H., Li, D., Wu, Y., Ji, Q., Shen, Q., Sun, T., Xiang, J., Zeng, W., Chen, Y., & Wang, Z. (2017). Extracranial schwannoma in the carotid space: A retrospective review of 91 cases. Head & Neck, 39(1), 42–47. doi:10.1002/hed.24523.
Mankin, H. J., & Mankin, K. P. (2014). Schwannoma: a rare benign tumor of soft tissues. Musculoskeletal Surgery, 98(2), 95–99. doi:10.1007/s12306-014-0333-0.
Ilagan, C., Poliakin, L., Asarian, A., Xiao, P., & Sirsi, S. (2019). Anterior knee schwannoma. Journal of Surgical Case Reports, 2019(9), rjz236. doi:10.1093/jscr/rjz236.
Scripko, P. D., Venteicher, A. S., & Plotkin, S. R. (2014). Nerve Sheath Tumors. In Encyclopedia of the Neurological Sciences (pp. 346-349). Elsevier Inc.. doi:10.1016/B978-0-12-385157-4.00488-7.
Baccon, J., Wellons, J. C., & Rizk, E. B. (2015). Pediatric peripheral nerve tumors. In Nerves and nerve injuries (pp. 839-846). Academic Press. doi:10.1016/B978-0-12-802653-3.00102-0.
Jiang, S., Shen, H., & Lu, H. (2019). Multiple schwannomas of the digital nerves and common palmar digital nerves: An unusual case report of multiple schwannomas in one hand. Medicine, 98(10), e14605. doi:10.1097/MD.0000000000014605.
He, Y. A., Yan, C., Chen, Y., Zhu, L. G., Cai, M., & Wang, W. T. (2020). Management of Schwannoma in the hepatoduodenal ligament: A case report and review of the literature. Medicine, 99(3), e18797. doi:10.1097/MD.0000000000018797.
Saggini, A., Di Prete, M., D'Amico, F., Lora, V., & Orlandi, A. (2019). Glandular Schwannoma: An Uncommon Variant of Schwannoma with Controversial Histogenesis. Dermatopathology (Basel, Switzerland), 6(4), 206–212. doi:10.1159/000503599.
Hide, I. G., Baudouin, C. J., Murray, S. A., & Malcolm, A. J. (2000). Giant ancient schwannoma of the pelvis. Skeletal Radiology, 29(9), 538-542. doi:10.1007/s002560000266.
Isobe, K., Shimizu, T., Akahane, T., & Kato, H. (2004). Imaging of ancient schwannoma. AJR. American Journal of Roentgenology, 183(2), 331–336. doi:10.2214/ajr.183.2.1830331.
Choudry, H. A., Nikfarjam, M., Liang, J. J., Kimchi, E. T., Conter, R., Gusani, N. J., & Staveley-O'Carroll, K. F. (2009). Diagnosis and management of retroperitoneal ancient schwannomas. World Journal of Surgical Oncology, 7, 12. doi:10.1186/1477-7819-7-12.
Malizos, K., Ioannou, M., & Kontogeorgakos, V. (2013). Ancient schwannoma involving the median nerve: a case report and review of the literature. Strategies in Trauma and Limb Reconstruction, 8(1), 63–66. doi: 10.1007/s11751-013-0158-7.
Schaberg K., Born D., Robert V Rouse R.V. (2015). Surgical pathology criteria: Schwanoma. Stanford Medicine. Available online: http://surgpathcriteria.stanford.edu/peripheral-nerve/schwannoma/ (accessed on December 2020).
Al-Shudifat, A., Mafrachi, B., Al-Ani, A., Qaisi, A., & Bustami, N. (2020). Ancient Schwannoma affecting the intracranial portion of the trigeminal nerve: A case report. Surgical Neurology International, 11, 426. doi:10.25259/SNI_464_2020.
Wierzbicki, V., Pesce, A., Marrocco, L., Piccione, E., Frati, A., & Caruso, R. (2016). Ancient Schwannoma of the Cauda Equina: Our Experience and Review of the Literature. Case Reports in Surgery, 2016, 7930521. doi:10.1155/2016/7930521.
Woodruff, J. M., Godwin, T. A., Erlandson, R. A., Susin, M., & Martini, N. (1981). Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. The American Journal of Surgical Pathology, 5(8), 733–744. PMID: 7337161.
Alam, K., Jain, A., & Misra, A. (2013). Cellular schwannoma masquerading as malignant peripheral nerve sheath tumour: a diagnostic dilemma. Case Reports, 2013, bcr2012008435. doi:10.1136/bcr-2012-008435.
Kim, E. R., Choi, E. O., Lee, K. B., Kang, C. H., Kim, Y. T., & Park, I. K. (2014). A recurrent cellular schwannoma. The Korean Journal of Thoracic and Cardiovascular Surgery, 47(5), 487. doi:10.5090/kjtcs.2014.47.5.487.
Alberghini, M., Zanella, L., Bacchini, P., & Bertoni, F. (2001). Cellular schwannoma: a benign neoplasm sometimes overdiagnosed as sarcoma. Skeletal Radiology, 30(6), 350-353. doi:10.1007/s002560100356.
Koyye, R. T., Mahadevan, A., Santosh, V., Chickabasaviah, Y. T., Govindappa, S. S., Hegde, T., & Shankar, S. K. (2003). A rare case of cellular schwannoma involving the trigeminal ganglion. Brain Tumor Pathology, 20(2), 79-83. doi:10.1007/BF02483451.
Landeiro, J. A., Ribeiro, C. H., Galdino, A. C., Taubman, E., & Guarisch, A. J. (2003). Cellular schwannoma: a rare spinal benign nerve-sheath tumor with a pseudosarcomatous appearance: case report. Arquivos de Neuro-psiquiatria, 61(4), 1035-1038. doi:10.1590/s0004-282x2003000600029.
Laforga, J. B. (2003). Cellular schwannoma: report of a case diagnosed intraoperatively with the aid of cytologic imprints. Diagnostic Cytopathology, 29(2), 95-100. doi:10.1002/dc.10314.
Pekmezci, M., Reuss, D. E., Hirbe, A. C., Dahiya, S., Gutmann, D. H., Von Deimling, A., & Perry, A. (2015). Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Modern Pathology, 28(2), 187-200. doi:10.1038/modpathol.2014.109.
D'Almeida Costa, F., Dias, T. M., Lombardo, K. A., Raghunathan, A., Giannini, C., Kenyon, L., & Rodriguez, F. J. (2020). Intracranial cellular schwannomas: a clinicopathological study of 20 cases. Histopathology, 76(2), 275-282. doi:10.1111/his.13967.
Al-Otieschan, A. T., Manohar, M. B., Gangopadhyay, K., & Tulbah, A. (2002). Cellular schwannoma of the paranasal sinuses: initial report of a case. Ear, Nose & Throat Journal, 81(4), 281-284. doi:10.1177/014556130208100418.
Zhang, S., Wang, X., Zhang, Z., & Chen, Y. (2008). Tanycytic ependymoma arising from the right lateral ventricle: A case report and review of the literature. Neuropathology, 28(4), 427–432. doi:10.1111/j.1440-1789.2007.00857.x.
Patocskai, E. J., Tabatabaian, M., & Thomas, M. J. (2002). Cellular schwannoma: a rare presacral tumour. Canadian Journal of Surgery, 45(2), 141. PMID: 11939658.
Kang, S. K., Chang, S. E., Choi, J. H., Sung, K. J., Moon, K. C., & Koh, J. K. (2002). A case of cellular schwannoma of the skin presenting as a large ulcerated tumor on the ankle. The Journal of Dermatology, 29(1), 28-32. doi:10.1111/j.1346-8138.2002.tb00161.x.
Chandran, R. S., Patil, A. K., Prabhakar, R. B., & Balachandran, K. (2018). Melanotic schwannoma of spine: illustration of two cases with diverse clinical presentation and outcome. Asian Journal of Neurosurgery, 13(3), 881. doi:10.4103/ajns.AJNS_353_16.
Mahato, D., Vivas-Buitrago, T., Gassie, K., Jentoft, M., Tavanaiepour, D., & Quinones-Hinojosa, A. (2018). Intracranial melanotic schwannomas: a rare variant with unusual adherent features. Journal of Neuro-oncology, 136(2), 299-306. doi:10.1007/s11060-017-2653-z.
Spina, A., Gagliardi, F., Boari, N., Terreni, M. R., & Mortini, P. (2015). Intracranial melanotic schwannomas. Journal of Neurological Surgery Part A: Central European Neurosurgery, 76(05), 399-406. doi:10.1055/s-0034-1393926.
Alexiev, B. A., Chou, P. M., & Jennings, L. J. (2018). Pathology of melanotic schwannoma. Archives of Pathology & Laboratory Medicine, 142(12), 1517-1523. doi:10.5858/arpa.2017-0162-RA.
Culhaci, N., DikicioÄlu, E., MeteoÄŸlu, I., & Boylu, Åž. (2003). Multiple melanotic schwannoma. Annals of Diagnostic Pathology, 7(4), 254-258. doi:10.1016/s1092-9134(03)00073-x.
Kurtkaya-Yapicier, O., Scheithauer, B. W., & Woodruff, J. M. (2003). The pathobiologic spectrum of Schwannomas. Histology and Histopathology, 18: 925-934. doi:10.14670/HH-18.925.
Li, X. L., & Dai, S. D. (2019). Melanotic Schwannoma: two cases of rare lesions. Pathology & Oncology Research, 25(4), 1667-1670. doi:10.1007/s12253-018-0417-5.
Akiyoshi, T., Ueda, Y., Yanai, K., Yamaguchi, H., Kawamoto, M., Toyoda, K., & Ohuchida, J. (2004). Melanotic schwannoma of the pancreas: report of a case. Surgery Today, 34(6), 550-553. doi:10.1007/s00595-004-2744-2.
Er, U., Kazanci, A., Eyriparmak, T., Yigitkanli, K., & Senveli, E. (2007). Melanotic schwannoma. Journal of Clinical Neuroscience, 14(7), 676-678. doi:10.1016/j.jocn.2006.03.010.
Küsters-Vandevelde, H. V., van Engen-van Grunsven, I. A., Küsters, B., van Dijk, M. R., Groenen, P. J., Wesseling, P., & Blokx, W. A. (2010). Improved discrimination of melanotic schwannoma from melanocytic lesions by combined morphological and GNAQ mutational analysis. Acta Neuropathologica, 120(6), 755-764. doi:10.1007/s00401-010-0749-z.
Choi, S. E., Cha, Y. J., Kim, J., Cha, H., Seo, J., Kuh, S. U., & Kim, S. H. (2017). A rare case of aggressive melanotic schwannoma occurred in spinal nerve of a 59-year-old male. Journal of Pathology and Translational Medicine, 51(5), 505. doi:10.4132/jptm.2017.01.04.
Matsuoka, Y., Kakudo, N., Fukui, M., & Kusumoto, K. (2019). Giant plexiform schwannoma in the plantar aspect of the foot: a case report. Journal of Surgical Case Reports, 2019(11), rjz352. doi:10.1093/jscr/rjz352.
Jacobson, J. M., Felder III, J. M., Pedroso, F., & Steinberg, J. S. (2011). Plexiform schwannoma of the foot: a review of the literature and case report. The Journal of Foot and Ankle Surgery, 50(1), 68-73. doi:10.1053/j.jfas.2010.07.002.
Mohammed, S. A., Pressman, M. M., Schmidt, B., & Babu, N. (2014). Case presentations and review of plexiform schwannoma in the foot. The Journal of Foot and Ankle Surgery, 53(2), 179-185. doi:10.1053/j.jfas.2013.12.020.
Destro, F., Sharma, S., Maestri, L., Vella, C., Collini, P., & Riccipetitoni, G. (2021). Visceral plexiform schwannoma: A case series. Molecular and Clinical Oncology, 14(1), 1-1. doi:10.3892/mco.2020.2176.
Berg, J. C., Scheithauer, B. W., Spinner, R. J., Allen, C. M., & Koutlas, I. G. (2008). Plexiform schwannoma: a clinicopathologic overview with emphasis on the head and neck region. Human Pathology, 39(5), 633-640. doi:10.1016/j.humpath.2007.10.029.
Talwalkar, S. C., Cutler, L., & Stilwell, J. H. (2005). Multiple plexiform schwannoma of the hand and forearm: a long-term follow-up. Journal of Hand Surgery, 30(4), 358-360. doi:10.1016/j.jhsb.2005.04.008.
Lambade, P. N., Lambade, D., Saha, T. K., Dolas, R. S., & Dhobley, A. (2013). Unusual intramaxillary plexiform schwannoma. Oral and Maxillofacial Surgery, 17(2), 137-140. doi:10.1007/s10006-012-0345-6.
Hart, J., Gardner, J. M., Edgar, M., & Weiss, S. W. (2016). Epithelioid schwannomas. The American Journal of Surgical Pathology, 40(5), 704-713. doi:10.1097/PAS.0000000000000589.
Jo, V. Y., & Fletcher, C. D. (2017). SMARCB1/INI1 loss in Epithelioid Schwannoma. The American Journal of Surgical Pathology, 41(8), 1013-1022. doi:10.1097/PAS.0000000000000849.
Chan, A. W., Mak, S. M., & Chan, G. P. (2011). Benign epithelioid schwannoma of intraparotid facial nerve. Pathology, 43(3), 280–282. doi:10.1097/PAT.0b013e3283437cc0.
Krishnamurthy, T., & SR Niveditha MD, D. N. B. (2014). Benign epithelioid peripheral nerve sheath tumour resembling schwannoma. The Malaysian Journal of Pathology, 36(3), 217. PMID: 25500523.
Yuen, T., & Kaye, A. H. (2004). Intracranial epithelioid schwannoma–a case report. Journal of Clinical Neuroscience, 11(1), 91-95. doi:10.1016/s0967-5868(03)00114-0.
Fisher, B. J., & Dennis, K. E. (2006). Malignant epithelioid cranial nerve sheath tumor: case report of a radiation response. Journal of Neuro-oncology, 78(2), 173-177. doi:10.1007/s11060-005-9083-z.
Neurosurgery. (2018). Spinal Schwannoma Classification. Neurosurgery directory. Available online: https://neurosurgery.directory/2018/09/19/spinal-schwannoma-classification/ (accessed on December 2020).
Scheithauer, B. W., Woodruff, J. M., & Spinner, R. J. (2010). Peripheral nerve sheath tumors. Practical Surgical Neuropathology. Philadelphia: Elsevier, 235-85. doi:10.1016/B978-0-443-06982-6.00012-2.
Yoon, J., Cusimano, M., & Munoz, D. G. (2019). Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing. Journal of Clinical Neuroscience, 66, 231-234. doi:10.1016/j.jocn.2019.05.002.
Yau, W. H., & Ameratunga, M. (2020). Combination of BRAF and MEK inhibition in BRAF V600E mutant low-grade ganglioglioma. Journal of clinical Pharmacy and Therapeutics, 45(5), 1172–1174. doi:10.1111/jcpt.13112.
Mansour, S., Luther, E., Eichberg, D. G., Shah, A., Echeverry, N., Humayun Gultekin, S., Ivan, M., & Komotar, R. (2020). Multifocal Intracranial Ganglioglioma in a Sexagenarian: Case Report and Review of the Current Literature. World Neurosurgery, 138, 498–503. doi:10.1016/j.wneu.2019.12.084.
Mpairamidis, E., Alexiou, G. A., Stefanaki, K., Sfakianos, G., & Prodromou, N. (2008). Brainstem ganglioglioma. Journal of Child Neurology, 23(12), 1481–1483. doi:10.1177/0883073808319316.
Im, S. H., Chung, C. K., Cho, B. K., Wang, K. C., Yu, I. K., Song, I. C., Cheon, G. J., Lee, D. S., Kim, N. R., & Chi, J. G. (2002). Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. Journal of Neuro-oncology, 59(2), 173–183. doi:10.1023/a:1019661528350.
Pujadas, E., Chen, L., & Rodriguez, F. J. (2019). Pathologic and molecular aspects of anaplasia in circumscribed gliomas and glioneuronal tumors. Brain Tumor Pathology, 36(2), 40–51. doi:10.1007/s10014-019-00336-z.
Lisievici, A. C., Georgescu, T. A., Pasov, D., Tascu, A., Lisievici, M. G., & Sajin, M. (2018). Grading Gangliogliomas: a Short Case Series with Clinico-Imagistic and Immunohistopathological Correlations. Maedica, 13(3), 241-249. doi:10.26574/maedica.2018.13.3.241.
Majores, M., von Lehe, M., Fassunke, J., Schramm, J., Becker, A. J., & Simon, M. (2008). Tumor recurrence and malignant progression of gangliogliomas. Cancer, 113(12), 3355–3363. doi:10.1002/cncr.23965.
Yoon, J., Cusimano, M., & Munoz, D. G. (2019). Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing. Journal of Clinical Neuroscience, 66, 231-234. doi:10.1016/j.jocn.2019.05.002.
Prasad, G. L., Kumar, R., Kurwale, N., & Suri, V. (2016). Intraventricular Gangliogliomas: A Review. World Neurosurgery, 87, 39–44. doi:10.1016/j.wneu.2015.11.044.
Odia, Y. (2016). Gangliocytomas and gangliogliomas: review of clinical, pathologic and genetic features. Clinics in Oncology, 1. http://clinicsinoncology.com/.
Blümcke, I., Coras, R., Wefers, A. K., Capper, D., Aronica, E., Becker, A., Honavar, M., Stone, T. J., Jacques, T. S., Miyata, H., Mühlebner, A., Pimentel, J., Söylemezoğlu, F., & Thom, M. (2019). Review: Challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype-phenotype analysis. Neuropathology and Applied Neurobiology, 45(2), 95–107. doi:10.1111/nan.12522.
Matsumoto, K., Tamiya, T., Ono, Y., Furuta, T., Asari, S., & Ohmoto, T. (1999). Cerebral gangliogliomas: clinical characteristics, CT and MRI. Acta Neurochirurgica, 141(2), 135–141. doi:10.1007/s007010050277.
Brat, D. J., Parisi, J. E., Kleinschmidt-DeMasters, B. K., Yachnis, A. T., Montine, T. J., Boyer, P. J., Powell, S. Z., Prayson, R. A., McLendon, R. E., & Neuropathology Committee, College of American Pathologists (2008). Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. Archives of Pathology & Laboratory Medicine, 132(6), 993–1007. doi:10.1043/1543-2165(2008)132[993:SNUARO]2.0.CO;2.
MartÃnez-Ricarte, F., MartÃnez-Saez, E., Cicuendez, M., Cordero, E., Auger, C., Toledo, M. (2016). Atypical ganglioglioma with BRAF V600E mutation: a case report and review of the literature. Revista de neurologia, 62(10), 455-459. PMID: 27149188.
Slegers, R. J., & Blumcke, I. (2020). Low-grade developmental and epilepsy associated brain tumors: a critical update 2020. Acta Neuropathologica Communications, 8(1), 27. doi:10.1186/s40478-020-00904-x.
Kuten, J., Kaidar-Person, O., Vlodavsky, E., Postovsky, S., Billan, S., Kuten, A., & Bortnyak-Abdah, R. (2012). Anaplastic ganglioglioma in the spinal cord: case report and literature review. Pediatric Neurosurgery, 48(4), 245–248. doi:10.1159/000348556.
Khan, A., Sadek, A. R., Fabian, M., & Nader-Sepahi, A. (2020). Spinal anaplastic ganglioglioma. British Journal of Neurosurgery, 1–4. Advance online publication. doi:10.1080/02688697.2020.1823936.
Lee, C. C., Wang, W. H., Lin, C. F., Chen, H. H., Chen, S. C., Lin, S. C., & Hsu, S. P. (2012). Malignant transformation of supratentorial ganglioglioma. Clinical Neurology and Neurosurgery, 114(10), 1338-1342. doi:10.1016/j.clineuro.2012.03.018.
Zanello, M., Pages, M., Tauziède-Espariat, A., Saffroy, R., Puget, S., Lacroix, L. & Varlet, P. (2016). Clinical, imaging, histopathological and molecular characterization of anaplastic ganglioglioma. Journal of Neuropathology & Experimental Neurology, 75(10), 971-980. doi:10.1093/jnen/nlw074.
Southwell, D. G., Garcia, P. A., Berger, M. S., Barbaro, N. M., & Chang, E. F. (2012). Long-term seizure control outcomes after resection of gangliogliomas. Neurosurgery, 70(6), 1406-1414. doi:10.1227/NEU.0b013e3182500a4c.
Jane, J. A., & Laws, E. R. (2006). Craniopharyngioma. Pituitary, 9(4), 323-326. doi:10.1007/s11102-006-0413-8.
Ramanbhavana, V. S., & Vara Prasad, K. S. (2019). A Case Series of Craniopharyngioma: Epidemiological Study and Management Analysis at Tertiary Care Center. Asian Journal of Neurosurgery, 14(4), 1196–1202. doi:10.4103/ajns.AJNS_67_19.
Hengartner, A. C., Prince, E., Vijmasi, T., & Hankinson, T. C. (2020). Adamantinomatous craniopharyngioma: moving toward targeted therapies. Neurosurgical Focus, 48(1), E7. /doi:10.3171/2019.10.FOCUS19705.
Rutenberg, M. S., Rotondo, R. L., Rao, D., Holtzman, A. L., Indelicato, D. J., Huh, S. (2020). Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. Journal of Neuro-oncology, 1-9. doi:10.1007/s11060-020-03432-9.
Moszczyńska, E., Prokop-Piotrkowska, M., Bogusz-Wójcik, A., Grajkowska, W., Szymańska, S., & Szalecki, M. (2020). Ki67 as a prognostic factor of craniopharyngioma’s recurrence in paediatric population. Child's Nervous System, 1-9. doi:10.1007/s00381-020-04519-4.
Jensterle, M., Jazbinsek, S., Bosnjak, R., Popovic, M., Zaletel, L. Z., Vesnaver, T. V., & Kotnik, P. (2019). Advances in the management of craniopharyngioma in children and adults. Radiology and Oncology, 53(4):388-396. doi:10.2478/raon-2019-0036.
Müller, H. L. (2014). Craniopharyngioma. Endocrine Reviews, 35(3), 513-543. doi:10.1210/er.2013-1115.
Lubuulwa, J., & Lei, T. (2016). Pathological and Topographical Classification of Craniopharyngiomas: A Literature Review. Journal of Neurological Surgery Reports, 77(3), e121–e127. doi:10.1055/s-0036-1588060.
Karavitaki, N., & Wass, J. A. (2008). Craniopharyngiomas. Endocrinology and Metabolism Clinics of North America, 37(1), 173-193. doi:10.1016/j.ecl.2007.10.012.
Cojocaru, E., Mihăilă, D., Leon-Constantin, M. M., Cobzaru, R. G., Rîpă, C. V., Trandafirescu, M. F., & Trandafir, L. M. (2019). Update in pediatric primary brain tumors-from histology to genetically defined tumors. Romanian journal of morphology and embryology. Revue roumaine de morphologie et embryologie, 60(3), 761-767. PMID: 31912084.
Brastianos, P. K., & Santagata, S. (2016). ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. European Journal of Endocrinology, 174(4), R139–R144. doi:10.1530/EJE-15-0957.
Whelan, R., Prince, E., Gilani, A., & Hankinson, T. (2020). The Inflammatory Milieu of Adamantinomatous Craniopharyngioma and Its Implications for Treatment. Journal of Clinical Medicine, 9(2), 519. doi:10.3390/jcm9020519.
Gupta, S., Bi, W. L., Larsen, A. G., Al-Abdulmohsen, S., Abedalthagafi, M., & Dunn, I. F. (2018). Craniopharyngioma: a roadmap for scientific translation. Neurosurgical Focus, 44(6), E12. doi:10.3171/2018.3.FOCUS1861.
Borrill, R., Cheesman, E., Stivaros, S., Kamaly-Asl, I. D., Gnanalingham, K., & Kilday, J. P. (2019). Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature. Child's Nervous System, 35(1), 169-173. doi:10.1007/s00381-018-3925-4.
Juratli, T. A., Jones, P. S., Wang, N., Subramanian, M., Aylwin, S., Odia, Y., Rostami, E., Gudjonsson, O., Shaw, B. L., Cahill, D. P., Galanis, E., Barker, F. G., 2nd, Santagata, S., & Brastianos, P. K. (2019). Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer, 125(17), 2910–2914. doi:10.1002/cncr.32197.
Karavitaki, N. (2014). Management of craniopharyngiomas. Journal of Endocrinological Investigation, 37(3), 219-228. doi:10.1007/s40618-013-0050-9.
Omay, S. B., Chen, Y. N., Almeida, J. P., Ruiz-Treviño, A. S., Boockvar, J. A., Stieg, P. E. (2017). Do craniopharyngioma molecular signatures correlate with clinical characteristics?. Journal of Neurosurgery, 128(5), 1473-1478. doi:10.3171/2017.1.JNS162232.
O'steen, L., & Indelicato, D. J. (2018). Advances in the management of craniopharyngioma. F1000Research, 7, F1000 Faculty Rev-1632. doi:10.12688/f1000research.15834.1.
Garnett, M. R., Puget, S., Grill, J., & Sainte-Rose, C. (2007). Craniopharyngioma. Orphanet Journal of Rare Diseases, 2(1), 1-7. doi:10.1186/1750-1172-2-18.
DOI: 10.28991/SciMedJ-2021-0304-8
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Brian Thabile Flepisi, Marissa Balmith